ADCT · ADC Therapeutics SA · Executive Compensation

$1.07 -0.04 (-3.60%) At close · Sep 11

Russell 2000 member Rebalance outlook locked

Market Cap

$136.60M

127.67M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ameet Mallik	Chief Executive Officer Jose “Pepe” Carmona Chief Financial Officer	$776,084	—	$1,046,500	—	$582,063	$48,503	$2,453,150
Mohamed Zaki	Chief Medical Officer	$690,121	—	$370,300	—	$431,325	$23,820	$1,515,566

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ameet Mallik	Chief Executive Officer Jose “Pepe” Carmona Chief Financial Officer	$746,235	$621,732	—	—	$425,354	$44,307	$1,837,628
Mohamed Zaki	Chief Medical Officer	$670,020	—	—	—	$318,260	$21,233	$1,009,513

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mohamed Zaki	Chief Medical Officer	$647,292	$1,475,000	$288,900	$1,701,000	$276,250	$15,409	$4,403,851
Ameet Mallik	Chief Executive Officer Jose “Pepe” Carmona Chief Financial Officer	$721,000	$705,065	$1,059,300	$881,250	$367,710	$45,100	$3,779,425

Key facts CIK 1771910 CUSIP H0036K147 13F (30d) 40 filings 40 filers Visit website Investor relations